Linux System Engineer (DevOps) (m/w/d)
Du bist ein Problemlöser, der die Zusammenarbeit liebt, um die bestmöglichen technischen Lösungen zu finden und du liebst Linux. Wir haben sehr komplexe Produkte und Du hast den Anspruch diese besser zu verstehen als wir.
Overcoming IVDR Challenges – A Webinar on November 8, 2022, at 18:00 CET
Join a unique virtual event examining the relevance of the new European In-Vitro Diagnostics Medical Device Regulation (EU)2017/746 (IVDR) for clinical laboratories. We share our experience in gaining IVDR certification for our clinical decision support solution MH Guide to give you a leg up. We hope to see you for this free-to-attend webinar on November 8th, 2022, at 18:00 CET. Click here to register.
Webinar: Deepen your knowledge on comprehensive genomic profiling
Join our educational webinar on comprehensive genomic profiling on Wednesday, October 5 at 6:00 PM CEST, to find out how your cancer patient can benefit from biomarker testing. Register for free https://event.on24.com/wcc/r/3923804/7192787FC3EE75423B64180F985FE7B5
MH Guide Webinar – 07.06.2022 12:00 am EST
Join our free-to-attend Live Webinar showcasing how MH Guide translates genomic tumor data into clinical evidence in a few minutes.
MH Guide 5.2 – Improved focus. Greater flexibility. Better usability.
When it comes to targeted cancer treatments, new biomarkers are continually found, and additional treatment options are approved. Keeping pace with those changes with MH Guide 5.2.
MH Guide Webinar – 28.04.2022 5:00 pm CET
Join our free-to-attend Live Webinar showcasing how to automatically identify clinically actionable biomarkers in molecular tumor profiles of individual patients.
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD).
What’s new in MH Guide 5.1
The MH Guide 5.1 upgrade introduces new features and improved capabilities to access more information and make therapy decisions clearer.
With head offices in Bonn, Germany, GENOPATH GbR is an association of 16 pathology institutes. The group formed to supply all member laboratories with top-quality and cutting-edge molecular diagnostic services that complement existing histological and cytological methods, making the comprehensive care available to every cancer patient.
MH Guide: Molecular tumor diagnostics in 7 steps
The MH Guide software claims to support therapy decisions in oncology. It can translate data obtained from molecular tumor diagnostic tests into clinically relevant knowledge. This overview illustrates the practical use of the MH Guide.